+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Agenus Inc - logo

Agenus is an immuno-oncology company that focuses on the discovery and development of treatments that engage the body's immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates. It is also developing Prophage, a heat shock protein-based autologous vaccine. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

From
From
Oncolytic Virus - Competitive Landscape, 2022 - Product Thumbnail Image

Oncolytic Virus - Competitive Landscape, 2022

  • Report
  • October 2022
  • 300 Pages
  • Global
From
Pancreatic Cancer - Competitive Landscape, 2024 - Product Thumbnail Image

Pancreatic Cancer - Competitive Landscape, 2024

  • Clinical Trials
  • December 2024
  • 550 Pages
  • Global
From
From
From
From
From
From
Head And Neck Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Head And Neck Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 3419 Pages
  • Global
From
Glioma - Competitive Landscape, 2023 - Product Thumbnail Image

Glioma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 450 Pages
  • Global
From
From
Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025 - Product Thumbnail Image

Kv1.3/1.5 Potassium Channel Blockers - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pancreatic Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Pancreatic Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 4317 Pages
  • Global
From
Melanoma - Pipeline Review, H2 2020 - Product Thumbnail Image

Melanoma - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 3809 Pages
  • Global
From
Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Agenus Inc (AGEN) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • September 2024
  • 53 Pages
From
From
Loading Indicator